United States· US:68071-2265_1d76541f-80dc-2a55-e063-6294a90aa5f9
Ofloxacin
A ofloxacin product containing ofloxacin, registered in United States by NuCare Pharmaceuticals,Inc.. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Ofloxacin is registered in 11 of 19 countries.
Countries holding a registration under ATC S01AE01 (ofloxacin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Ofloxacin · ATC S01AE01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ofloxacin costs, country by country.
Normalised to the WHO defined daily dose (0.4 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ofloxacin · price per daily dose (0.4 mg)
USD · FX 28 Sept 2026
- FR France$0.0016
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OFLOXACIN
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Country
- United States (US)
- ATC code
- S01AE01
- ATC class
- Ofloxacin
- Defined daily dose
- 0.4 mg, AT
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1168071-2265-1
- ndc1168071226511 BOTTLE, DROPPER in 1 CARTON (68071-2265-1) / 5 mL in 1 BOTTLE, DROPPER
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ofloxacin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandFloxalInPharm Sp. z o.o.
- NetherlandsOfloxacine Devatis 3 mg/ml, oogdruppels, oplossing, verpakking voor éénmalig gebruikDevatis GmbH
- BelgiumOfloxacin-Pos 3 mg/mlURSAPHARM Benelux
- CzechiaFLOXALDr. Gerhard Mann, Chem.- pharm. Fabrik GmbH, Berlín
- FinlandExocinAbbVie Oy
- FranceMONOOX 1,5 mg/0,5 ml, collyre en solution en récipient unidoseHORUS PHARMA
- SwedenOfloxacin mibe 3 mg/ml Ögondroppar, lösningmibe GmbH Arzneimittel
- United KingdomExocin 0.3% eye dropsSigma Pharmaceuticals Plc
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Floxal, Floxal Edo
- Belgium · Trafloxal, Trafloxal Edo
- Bulgaria · Медофлоксин, Офлоксацин Дра
- Cyprus · Cilox, Medofloxine
- Czechia · Floxal, Ofloxacin Unimed Pharma
- Germany · Floxal, Floxal Edo
- Estonia · Medofloxine, Ofloxin
- Spain · Exocin, Oflovir
- Finland · Exocin
- France · Exocine, Monoflocet
- United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
- Greece · Exocin, Oxatrex
- Croatia · Uniflox
- Hungary · Floxal, Grenis-Oflo
- Ireland · Exocin
- Italy · Dunaflot, Exocin
- Lithuania · Ofloxin, Uniflox
- Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
- Latvia · Ofloxin, Uniflox
- Malta · Uniflox Unimed Pharma
- Netherlands · Ofloxacine 200 Pch, Ofloxacine 400 Pch
- Poland · Floxal, Oflodinex
- Portugal · Audret, Bioquil
- Romania · Floxal, Ofloxacină Laropharm
- Sweden · Ofloxacin Mibe
- Slovakia · Medofloxine, Ofloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eebb2003-7c2f-4e3f-a834-99f9f86c8b02 GET /v1/drugs/eebb2003-7c2f-4e3f-a834-99f9f86c8b02?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "3",
"substance": "OFLOXACIN",
"productndc": "68071-2265",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA076622",
"marketing_category": "ANDA"
}See everything about ofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.